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The reprogramming of differentiated cells to pluripotent cells (induced pluripotent stem (iPS) cells) is known to be an inefficient process. We recently reported that cells with short telomeres cannot be reprogrammed to iPS cells despite their normal proliferation rates 1, 2 , probably reflecting the existence of 'reprogramming barriers' that abort the reprogramming of cells with uncapped telomeres. Here we show that p53 (also known as Trp53 in mice and TP53 in humans) is critically involved in preventing the reprogramming of cells carrying various types of DNA damage, including short telomeres, DNA repair deficiencies, or exogenously inflicted DNA damage. Reprogramming in the presence of pre-existing, but tolerated, DNA damage is aborted by the activation of a DNA damage response and p53-dependent apoptosis. Abrogation of p53 allows efficient reprogramming in the face of DNA damage and the generation of iPS cells carrying persistent DNA damage and chromosomal aberrations. These observations indicate that during reprogramming cells increase their intolerance to different types of DNA damage and that p53 is critical in preventing the generation of human and mouse pluripotent cells from suboptimal parental cells.
Nuclear reprogramming of differentiated cells into pluripotent stem cells is thought to be a possible source of patient-specific cells for transplantation therapies. Several strategies have been used to achieve nuclear reprogramming, including nuclear transplantation and cellular fusion 3 . Recently, the generation of iPS cells from differentiated cells was achieved by the overexpression of four transcription factors [4] [5] [6] . These factors are Oct4 (also known as Pou5f1), Sox2, Klf4 and c-Myc, although some of them are dispensable to reprogram certain cell types [4] [5] [6] [7] [8] [9] [10] [11] . Notably, only a small proportion of cells become pluripotent iPS cells (less than 1% (ref. 3); Supplementary Table 1 ). Several models have been proposed to explain the low efficiency of reprogramming 3 . Here we reasoned that a further explanation may be related to the presence of DNA damage in the cells undergoing reprogramming.
This notion is on the basis of our observations that murine fibroblasts with increased DNA damage owing to the presence of critically short telomeres (third generation (G3) telomerase-deficient mouse embryonic fibroblasts (MEFs), or G3 Terc 2/2 MEFs) cannot be reprogrammed to iPS cells 1, 2 , despite the fact that the cells have normal proliferation rates 12 ( Supplementary Fig. 1 ) and are able to spontaneously immortalize and be transformed by oncogenes 12 . iPS cell generation from G3 Terc 2/2 MEFs can be restored after reelongation of the shortest telomeres by telomerase 1, 2 , indicating that damaged/uncapped telomeres are responsible for their failure to reprogram. These observations suggest that an important impediment for reprogramming is the existence of reprogramming barriers *These authors contributed equally to this work. Relative reprogramming efficiency (x-fold)
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Relative reprogramming efficiency (x-fold) P < 0.0001 P < 0.001 . p53-null MEFs were reprogrammed with an efficiency that was on average fourfold higher than the wild-type MEFs (Fig. 1a-c and Supplementary Table 1 ), suggesting that p53 limits reprogramming of wild-type MEFs. We extended these findings to the reprogramming of BJ human foreskin fibroblasts with four factors (Oct4, Sox2, Klf4 and c-Myc). The simultaneous infection with a retrovirus expressing short hairpin RNA (shRNA) against p53 (p53 shRNA) resulted in a tenfold increase in reprogramming efficiency compared to BJ fibroblast controls (Fig. 1d, e) . Furthermore, p53-null iPS cell colonies appeared 3 days earlier than in the p53-proficient controls. G3 Terc 2/2 MEFs showed a tenfold decrease in reprogramming efficiency compared to wild-type MEFs (Fig. 1a-c (Fig. 1a-c and Supplementary Table 1) . We extended these results to other sources of DNA damage, such as low doses of c-irradiation and ultraviolet light. In both cases, irradiated MEFs showed lower reprogramming efficiencies than the non-irradiated controls (Fig. 1f) . Co-infection of 
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Reprogramming day 9 n = 2 n = 2 p53 protein (a.u.) p21 protein (a.u.) wild-type MEFs with the three factors together with a retrovirus expressing p53 shRNA or the anti-apoptotic protein Bcl2, rendered the reprogramming of these cells essentially insensitive to these doses of DNA damage (Fig. 1f) . Together, these findings indicate that p53 limits reprogramming of mouse and human cells by restricting conversion of DNA-damaged cells into iPS cells, probably by the elimination of these cells by apoptosis 13, 15 . This effect is exacerbated in cells containing a higher proportion of DNA-damaged cells owing to their dysfunctional telomeres or after infliction of exogenous DNA damage.
Our data indicates that p53 becomes sensitized to DNA damage once cells engage the iPS cell program. We sought to find direct evidence of p53 activity at early times during iPS cell formation before the appearance of typical iPS cell colonies. For this, we quantified the percentage of cells undergoing apoptosis at days 9-10 and 11-13 after infection, at the time of induction of pluripotency 8, 9 . A significant proportion (10% and 15%) of wild-type cells undergo apoptosis at days 9-10 and 11-13 after infection, respectively (Fig. 2a-c) . This is further increased to 40% in G3 Terc 2/2 cultures at 9-13 days after infection (Fig. 2a-c) , in agreement with their lower iPS cell yields (Fig. 1a-c) . Notably, apoptosis was essentially abrogated in p53 2/2 and G3 Terc 2/2 p53 2/2 cells at 9-13 days after infection (Fig. 2a-c) , whereas no differences in necrosis were observed (Fig. 2a-c) . The increased apoptosis in wild-type and G3 Terc 2/2 cultures at day 9 of reprogramming was accompanied by p53 and p21 (also referred as Cdkn1a) protein levels similar to those of c-irradiated wild-type MEFs, while this was not observed in the p53-null cultures (Fig. 2d, e) . These results indicate that p53 limits reprogramming by inducing apoptosis of suboptimal cells at the time of pluripotency induction, in agreement with Bcl2-overexpression allowing normal reprogramming of cells with exogenously inflicted DNA damage (Fig. 1f) . The activity of p53 restricting reprogramming of suboptimal cells is readily observed in wild-type cells and it is further exacerbated in G3 Terc 2/2 cells, which contain a higher proportion of damaged cells (Fig. 3a) , which persisted in the isolated iPS cell clones (Fig. 3b) and the teratomas derived from them ( Supplementary Fig. 4d ). cH2ax and 53BP1 foci showed frequent co-localization, indicating a robust DDR activation (Fig. 3d, yellow arrows) . Furthermore, in the G3 Terc 2/2 p53
cultures, a significant proportion of cells with cH2ax foci (.75%) showed co-localization with the Trf1 (also known as Terf1) telomeric protein forming the so-called telomere-induced DNA damage foci (TIF) (Fig. 3c) , indicative of telomere dysfunction. Cells with pannuclear cH2ax staining were also increased in the p53-null cultures at day 9 after infection and in the corresponding iPS cell clones (Fig. 3a , b and white arrows in Fig. 3d ). Pan-nuclear cH2ax staining is associated with replication-induced DNA damage 16 , suggesting generation of this type of endogenous DNA damage during the reprogramming process 16 . Finally, we detected Atm phosphorylation in the p53-null cultures at day 9 after infection ( Fig. 3e) , a hallmark of Atm activation 17 and further indicating DDR activation during reprogramming of these cells.
To test the unique role of p53 in the elimination of DNA-damaged cells during reprogramming, we considered the effect of Atm and 53BP1 deficiencies on reprogramming. These two proteins participate in the repair of DNA breaks and, consequently, their absence increases the endogenous levels of DNA damage 18, 19 . Furthermore, the two proteins participate in the signalling of DNA damage to p53 (refs 18, 19) . MEFs deficient in either Atm or 53BP1 showed a decreased reprogramming efficiency compared to wild-type controls (Fig. 3f, g ), which might reflect increased endogenous DNA damage in these cultures 18, 19 . These results are in agreement with the central role of p53 as the integrator of several and redundant DNA damage signalling pathways, whereas other upstream components of the DDR, such as Atm or 53BP1, are not essential to prevent the reprogramming of DNA-damaged cells.
We wondered whether reprogramming of p53-null cultures in the face of DNA damage was accompanied by increased chromosomal damage. Short/uncapped telomeres are known to lead to chromosome end-to-end fusions 12 . p53 2/2 iPS cells showed sixfold more end-to-end fusions than wild-type iPS cells (Fig. 4a, c) , and this was increased by 40-and 37-fold in G3 Terc 2/2 p53 2/2 and G3 Terc 2/2 iPS cells, respectively (Fig. 4a, c) . Of note, G3 Terc 2/2 iPS cells represent rare reprogramming events (Fig. 1a) after widespread apoptotic death (Fig. 2a-c) , which may explain the high levels of fusions in the face of functional p53. Chromosomal breaks/fragments were also increased in p53 2/2 iPS cells compared to wild-type iPS cells (sixfold), and further increased in G3 Terc 2/2 and G3 Terc 2/2 p53 2/2 iPS cells (13-and 10-fold, respectively) (Fig. 4b) Red arrows, end-to-end fusions. Original magnification, 3100. d, Percentage of signal-free ends. n 5 telomeres used for the analysis. Chisquare test is used for statistics. e, Average telomere elongation (kilobase (kb)) in iPS cell clones compared to parental MEFs. n 5 telomeres used for the analysis. At least two independent iPS cell clones were used per genotype. MEF passage number 5 3; iPS cell passage number 5 4-6. Error bars, s.e.m. f, Summary illustrating that p53 constitutes a main barrier to reprogramming of cells with increased DNA damage by preventing that they become iPS cells.
undetectable telomere signals or 'signal-free ends', compared to only 0.29% of signal-free ends in wild-type iPS cells (Fig. 4d) .
Telomeres undergo telomerase-dependent elongation during reprogramming-a process that continues after reprogramming until iPS cells clones acquire the typically long telomeres of embryonic stem (ES) cells 1, 2 . Telomeres were similarly elongated in wild-type and p53-null iPS cells compared with the parental MEFs, but suffered further shortening in the telomerase-deficient G3 Terc 2/2 and G3 Terc 2/2 p53 2/2 iPS cells (Fig. 4e) . These results indicate that the p53-deficiency allows reprogramming of G3 Terc 2/2 cells independently of telomere length.
Furthermore, we tested whether p53-abrogation in p53 2/2 and G3 Terc 2/2 p53 2/2 iPS cells had an affect on their ability to contribute to mouse chimaerism and teratomas. Although some of the p53 2/2 and G3 Terc 2/2 p53 2/2 iPS cell clones lost the typical rounded iPS cell morphology after expansion ( Supplementary Fig. 2 ), we were able to obtain chimaeras from p53 2/2 and G3 Terc 2/2 p53 2/2 iPS cells by picking individual iPS cell colonies with robust Nanog and Oct4 expression (Supplementary Table 2 and Supplementary Figs 3 and  4a) . p53 2/2 chimaeras were able to contribute to the germ line, however, the only G3 Terc 2/2 p53 2/2 chimaera obtained died at 14 days of age with severe intestinal atrophy (Supplementary Table  2 ). All of the p53 2/2 and G3 Terc 2/2 p53 2/2 iPS cell clones tested were able to form teratomas ( Supplementary Fig. 4b, c) . Notably, teratomas derived from G3 Terc 2/2 p53 2/2 iPS cells showed abundant cH2ax staining and anaphase bridges concomitant with lower p21 and apoptosis levels than wild-type teratomas ( Supplementary  Fig. 4d ), indicating that DDR activation persists during the differentiation of p53-null iPS cell clones.
In summary, these data indicate that p53 constitutes a main barrier to reprogramming of wild-type cells, which is exacerbated in cells with pre-existing DNA damage (that is, cells with short telomeres or deficient for Atm and 53BP1) and in cells in which DNA damage has been exogenously inflicted (irradiated cells). In this manner, suboptimal cells carrying DNA damage are eliminated by p53-dependent apoptosis and prevented from becoming iPS cells (Fig. 4f) . These results agree with previous findings showing that p53 downregulation improves reprogramming efficiency 20 . A p53-dependent counterselection of DNA-damaged cells during reprogramming is shown by increased Atm phosphorylation and increased DNA damage foci both in p53 2/2 and G3 Terc 2/2 p53 2/2 cultures. Given that some of the reprogramming factors promote tumorigenesis in vivo 21 , it is tempting to propose that the observed DDR in p53 2/2 cultures might be equivalent to the oncogene-induced DDR reported in the context of malignant transformation 22, 23 . In both models, reprogramming and transformation, p53 is critical to control the spreading of damaged cells.
METHODS SUMMARY
MEFs from the indicated genotypes were reprogrammed as described 1 . Human foreskin fibroblasts (BJ) were reprogrammed as described 5 . For quantification of iPS cell generation efficiency, retroviral transduction was measured in parallel infections containing the reprogramming factors plus a green fluorescent protein (GFP) retroviral plasmid, followed by FACS analysis at day 3. The total number of iPS cell colonies was counted after staining plates for alkaline phosphatase activity (AP detection kit, Chemicon International) following the manufacturer's instructions. Supplementary Table 1 shows a summary of the different reprogramming efficiencies.
Apoptosis was determined by annexin A5 staining and quantified using a FACS Canto. Analysis of the DDR was performed by high-throughput microscopy and western blotting as described before 16 . Analyses of telomere length and chromosomal aberrations were performed as described 1 . Chimaeras were derived from iPS cells as described 1 . For teratoma generation (nu/nu) mice were subcutaneously injected with 1 3 10 6 cells of each iPS cell clone. Protein and RNA analyses were performed following standard procedures.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Mice, cells and culture conditions. 14, 24 . The genetic background for all genotypes was a pure C57BL/6 background.
Primary MEFs (passage 2) were obtained from embryos of the indicated Terc and p53 genotypes as described previously 14, 24 . Atm 2/2 and 53BP1 2/2 MEFs and their corresponding wild-type controls were obtained from the null-mouse strains described before 19, 25 . MEFs were cultured in standard DMEM medium with 10% FBS (Gibco). ES and iPS cells were cultured in DMEM (high glucose) supplemented with serum replacement (KSR, Invitrogen), Lif (1,000 U ml 21 ), non-essential amino acids, glutamax and b-mercaptoethanol. C57BL/6 ES cells were derived at the Transgenic Mice Unit of the CNIO from C57BL/6 blastocysts. Generation of mouse iPS cells. Reprogramming of primary (passage 2-4) MEFs was performed as previously described 1 following modifications of a previous protocol 26 . In brief, primary MEFs of the indicated genotypes in a pure C57BL/6 background were seeded in 6-well plates (0.25-1 3 10 5 cells per well). They were infected four times in the next two days with a cocktail of the retroviral constructs pMXsOct3/4, pMXsKlf4 and pMXsSox2 as described 1 . Reprogramming was assessed 2 weeks after infection by counting alkaline-phosphatase-positive colonies. Alkaline phosphatase staining was performed according to manufacturer's instructions (Alkaline Phosphatase Detection kit; Millipore). The results were normalized to the respective efficiencies of retroviral transduction as assessed by transducing with the three retroviruses pMXsOct3/4, pMXsKlf4 and pMXsSox2, plus a retrovirus expressing GFP. Absolute reprogramming efficiencies are shown in Supplementary Table 1. The efficiency of reprogramming was also calculated as the relative change compared to that of wild-type MEFs (Fig. 1 ). Colonies were picked after 2 weeks and expanded on feeder fibroblasts using standard procedures. Generation of human iPS cells. Reprogramming of BJ human foreskin fibroblasts (passage 15; obtained from the American Type Culture Collection (ATCC)) was done as previously described 5, 27 . In brief, retroviral supernatants were produced in HEK-293T cells (5 3 10 6 cells per 100-mm-diameter dish) transfected with the ecotropic packaging plasmid pCL-Ampho (4 mg) together with one of the following retroviral constructs (4 mg): pMXs-hKlf4, pMXs-hSox2 or pMXs-hOct4 (obtained from Addgene and previously described) 5 . The retroviral construct expressing human shRNA against p53, pRETRO-Super, was provided by R. Bernards. Transfections and infections were performed the same as the mouse iPS cell reprogramming described earlier. Twenty-thousand BJ fibroblasts had been seeded the previous day (2 3 10 5 cells per 60-mm-diameter gelatin-coated dish) and received 1.5 ml of each of the corresponding retroviral supernatants (a total of either three or four-the fourth being the p53 shRNA retroviral supernatant). This procedure was repeated every 12 h for 2 days (a total of four additions). The day after infection was completed, media was replaced by human fibroblast media, and kept for a further 2 days. At day 8, cells were trypsinized and reseeded on feeder plate. At day 9, media was changed to human ES cell media. Cultures were maintained in the absence of drug selection with daily medium changes. At day 20, colonies with ES-like morphology became visible at the microscope. Colonies were picked after 3 weeks and expanded on feeder fibroblasts using standard procedures. Reprogramming of irradiated cells. Primary wild-type MEFs were exposed to UVC (2 J m 22
